Chronic Hypertension in Obstetric Context Clinical Trial
Official title:
Acute Control of Chronic Hypertension in Preeclampsia
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
The investigators seek to asses the effect of preexisting hypertension on the patient's response to treatment for severe hypertension in preeclampsia with severe features. The investigators hypothesize that successive administration of 40-60-80 mg of labetolol will reduce time to blood pressure control versus the standard dosing, 20-40-80 mg labetolol, recommended by the American College of Obstetricians and Gynecologists in 2015. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01885234 -
Aerobic Training in Pregnant Women With Gestational Diabetes and Chronic Hypertension
|
N/A | |
| Completed |
NCT03815110 -
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
|
||
| Recruiting |
NCT03824119 -
Postpartum NSAIDS and Maternal Hypertension
|
Phase 4 | |
| Active, not recruiting |
NCT04998942 -
Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy
|
N/A |